Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus

Neuroendocrinology Letters

Volumn 33, Issue SUPPL. 2, 2012, Pages 6-12

  Bláha, Vladimír ^a   Musil, František ^a   Šmahelová, Alena ^a   Tichá, Alena ^a   Hyšpler, Radomír ^a   Haluzík, Martin ^b   Lesná, Jana ^a   Sobotka, Luboš ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adipocyte fatty acid binding protein; Free fatty acids; Insulin resistance; Obesity; Type 1 diabetes mellitus

Indexed keywords

FATTY ACID; FATTY ACID BINDING PROTEIN 4;

ADULT; BIOIMPEDANCE SPECTROSCOPY; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; LOW CALORY DIET; MALE; OBESITY; PROTEIN BLOOD LEVEL; SPECTROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 84871049265     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Aldhahi W, Hamdy O (2003). Adipokines, inflammation and the endothelium in diabetes. Curr Diab Rep. 3: 293-298.
2. Arner P (2002). Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev. 18 (Suppl 2): S5-S9.
3. Awad S, Konstantin-Teodosiu D, Macdonald AI, Lobo ND (2009). Short-term starvation and mitochondrial dysfunction - a possible mechanism leasing to postoperative insulin resistance. Clinical Nutrition. 28: 497-509.
4. Carmen GY, Victor SM. Signalling mechanisms regulating lipolysis (2006). Cell Signal. 18: 401-408.
5. Damcot CM, Moffett SP, Feingold E, Barmana MM, Marshall JA, Hamman RF, Ferrell RE (2004). Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor γ interactively influence insulin sensitivity and body composition in males. Metabolism. 53: 303-9. (Pubitemid 38684689)
6. Duška F, Anděl M, Kuběna A, Macdonald AI (2005). Effects of acute starvation on insulin resistance in obese patients with and without type 2 diabetes mellitus. Clinical Nutrition. 24: 1056-1064. (Pubitemid 41782464)
7. Engl J, Ciardi C, Tatarczyk T, et al (2008). A-FABP - a biomarker associated with the metabolic syndrome and/or an indicator of weight change? Obesity (Silver Spring). 16: 1838-42.
8. Ferroni P, Basili S, Falco A et al (2004). Inflammation, insulin resistance and obesity. Curr Atheroscler Rep. 6: 424-431.
9. Féry F, Balasse EO (1994). Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM. Diabetes. 43: 1418-1425.
10. Fisher RM, Hoffstedt J, Hotamisligil GS et al (2002). Effects of obesity and weight loss on the expression of proteins involved in fatty acid metabolism in human adipose tissue. Int J Obes Relat Metab Disord. 26: 1379-1385. (Pubitemid 35221887)
11. Gao Y, Zhang YH, Zhang S, Li F, Wang S, Dai L, et al (2011) . Association of A-FABP gene polymorphism in intron 1 with meat quality traits in Junmu No. 1 white swine. Gene 487: 170-173.
12. Haider DG, Schindler K, Bohdjalian A, et al (2007). Plasma adipocyte and epidermal fatty acid-binding protein is reduced after weight loss in obesity. Diabetes Obes Metab. 9: 761-763. (Pubitemid 47261860)
13. Hsu WC, Okeke E, Cheung S, Keenan H, Tsui T, Cheng K, et al (2011). A cross-sectional characterization of insulin resistance by phenotype and insulin clamp in East Asian Americans with type 1 and type 2 diabetes. PLoS One. 6: e28311.
14. Kemmer FW (1992). Prevention of hypoglycemia during exercise in type 1 diabetes. Diabetes Care 15: 1732-1735.
15. Kilpatrick ES, Rigby AS, Atkin SL (2007). Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the diabetes control and complications trial. Diabetes Care. 30: 707-712. (Pubitemid 46354357)
16. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ (2003). Changing prevalence of overweight children and adolescents at onset of insulin- treated diabetes. Diabetes Care. 26: 2871-2875. (Pubitemid 37205561)
17. Maeda K, Cao H, Kono K, et al (2005). Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 1: 107-119. (Pubitemid 43960591)
18. Maeda K (2007). Role of adiponectin and adipocyte fatty acid binding protein in the metabolic syndrome. Diabetes Res Clin Pract. 77S: S17-S22.
19. Makowski L, Hotamisligil GS (2004). Fatty acid binding-proteins - the evolutionary crossroads of inflammatory and metabolic responses. J Nutr. 134: 2464S-2468S. (Pubitemid 39201622)
20. Mora S, Pressin JE (2002). An adipocentric view of signalling and intracellular trafficking. Diabetes Metab Res Rev. 18: 345-356. (Pubitemid 35256591)
21. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L, et al (2003). Insulin resistance related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 26: 1374-1379. (Pubitemid 36929165)
22. Pambianco G, Costacou T, Orchard TJ (2007). The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 30: 1248-1254. (Pubitemid 46684655)
23. Shen WJ, Liang Y, Hong R et al (2001). Characterization of the functional interaction of adipocyte lipid-binding protein with hormone-sensitive lipase. J Biol Chem. 276: 49443-49448.
24. Simón I, Escoté X, Vilarrasa N, Gómez J, Fernández-Real JM, Megía A, et al (2009) Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women. Obesity. 17: 1124-1128.
25. Stejskal D, Karpisek M (2006). Adipocyte fatty acid binding protein in Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest. 36: 621-625. (Pubitemid 44213828)
26. Stejskal D, Karpisek M, Bronsky J (2008). Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss. J Clin Lab Anal. 22: 380-2.
27. Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, et al (2005). Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care. 28: 2019-2024. (Pubitemid 41060978)
28. Tso A, Xu AW, Sham P et al (2007). Serum adipocyte fatty acid-binding protein as a new biomarker predicting the development of type 2 diabetes. Diabetes Care. 30: 2667-2672. (Pubitemid 47547818)
29. Xu A, Wang Y, Yu SJ et al (2006). Adipocyte fatty acid-binding protein is a plasma biomarker associated with obesity and Metabolic Syndrome. Clin Chem. 52: 405-413.
30. Xu A, Tso AW, Cheung BM et al (2007). Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5 year prospective study. Circulation. 115: 1537-1543. (Pubitemid 46648638)
31. Ye MH, Chen JL, Zhao GP, Zheng MQ, Wen J (2010). Associations of A-FABP and H-FABP markers with the content of intramuscular fat in Beijing-You chicken. Anim Biotechnol. 21: 14-24.
32. Zimmermann R, Strauss JG, Haemmerle G et al (2004). Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 306: 1383-1386. (Pubitemid 39532517)